Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer

Detalles Bibliográficos
Autor principal: Waldum, Helge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279847/
https://www.ncbi.nlm.nih.gov/pubmed/37346300
http://dx.doi.org/10.3389/fphar.2023.1170796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279847/
https://www.ncbi.nlm.nih.gov/pubmed/37346300
http://dx.doi.org/10.3389/fphar.2023.1170796

Ejemplares similares